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A B S T R A C T
The Chronic bee paralysis virus (CBPV) is the aetiological agent of chronic bee paralysis, a contagious disease
associated with nervous disorders in adult honeybees leading to massive mortalities in front of the hives. Some of
the clinical signs frequently reported, such as trembling, may be confused with intoxication syndromes.
Therefore, laboratory diagnosis using real-time PCR to quantify CBPV loads is used to conﬁrm disease. Clinical
signs of chronic paralysis are usually associated with viral loads higher than 108 copies of CBPV genome copies
per bee (8 log10 CBPV/bee). This threshold is used by the European Union Reference Laboratory for Bee Health
to diagnose the disease. In 2015, the accuracy of measurements of three CBPV loads (5, 8 and 9 log10 CBPV/bee)
was assessed through an inter-laboratory study. Twenty-one participants, including 16 European National
Reference Laboratories, received 13 homogenates of CBPV-infected bees adjusted to the three loads. Participants
were requested to use the method usually employed for routine diagnosis. The quantitative results (n = 270)
were analysed according to international standards NF ISO 13528 (2015) and NF ISO 5725-2 (1994). The
standard deviations of measurement reproducibility (SR) were 0.83, 1.06 and 1.16 at viral loads 5, 8 and 9 log10
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CBPV/bee, respectively. The inter-laboratory conﬁdence of viral quantiﬁcation (+/− 1.96 SR) at the diagnostic
threshold (8 log10 CBPV/bee) was +/− 2.08 log10 CBPV/bee. These results highlight the need to take into
account the conﬁdence of measurements in epidemiological studies using results from diﬀerent laboratories.
Considering this conﬁdence, viral loads over 6 log10 CBPV/bee may be considered to indicate probable cases of
chronic paralysis.
1. Introduction
Chronic bee paralysis is a worldwide viral disease of adult bees
associated with various clinical signs such as trembling and neurolo-
gical disorders. This disease is a serious threat to apiculture and con-
tributes to colony weakening, with signiﬁcant bee losses and mortalities
observed in front of the infected hives (Ribiere et al., 2010). The ae-
tiological agent is the chronic bee paralysis virus (CBPV), a non-en-
veloped virus with a segmented RNA genome. The CBPV genome has
been sequenced but this information did not allow for the virus to be
assigned to any speciﬁc family (Olivier et al., 2008a). The virus can be
transmitted horizontally (e.g. by the faeces of infected bees) or verti-
cally (by the queen) (Amiri et al., 2014; Ribiere et al., 2007). The dis-
ease is currently diagnosed through quantiﬁcation of the CBPV genome
in symptomatic or dead bees by reverse-transcription and quantitative
PCR (RT-qPCR) (Blanchard et al., 2007). A strong correlation between
chronic paralysis and high viral loads (over 8 log10 of CBPV genome
copies per bee [log10 CBPV/bee]) has been demonstrated, particularly
in symptomatic bees (Blanchard et al., 2007). The replication of the
virus in the integrative centres and sensory neuropiles could explain the
nervous disorders observed in diseased honeybees (Olivier et al.,
2008b). Viral loads of 10 log10 CBPV/bee or more have been correlated
with abnormal mortality and clinical signs of paralysis such as trem-
bling (Ribiere et al., 2010). This correlation between the viral load and
clinical signs has been conﬁrmed experimentally by infecting adult bees
with CBPV (Chevin et al., 2012; Youssef et al., 2015). Visible symptoms
such as trembling and crawling bees were observed in experimentally-
infected bees at day 5 post-infection and the infected bees died by day 7
post-infection. All the investigated bees were positive for CBPV with a
high viral load (over 12 log10 CBPV/bee). Such results were conﬁrmed
in a more recent study comparing the clinical signs and virus genome
load in CBPV-infected bees and bees infected with puriﬁed RNA seg-
ments of CBPV (Youssef et al., 2015). Five to six days post-infection, the
viral load was over 8 log10 CBPV/bee in both conditions. Quantifying
virus in bee samples may be important for identifying the aetiological
agent of adult honeybee mortalities. Currently, the clinical signs of
chronic bee paralysis can be confused with those of other diseases or
intoxication (Ribiere et al., 2010) or when several bee pathogens and
pesticides are acting synergistically (Bacandritsos et al., 2010).
The ANSES Sophia Antipolis Laboratory has been appointed as the
European Union Reference Laboratory (EURL) for bee health and
Reference Laboratory of the World Organisation for Animal Health
(OIE) for bee diseases. The main scope of its reference activities is not
only to harmonise the diagnosis of bee diseases by ensuring that the
National Reference Laboratories (NRLs) use EURL-validated methods,
but also to guarantee the proper use of these diagnostic methods.
The RT-qPCR method for quantifying the number of CBPV genome
copies per bee is one of such validated methods (Blanchard et al.,
2012). This method is used to quantify the CBPV load between 4 to 10
log10 CBPV/bee with an accuracy of 0.5 log10 CBPV/bee. This method
has been implemented in several European NRLs or oﬃcial laboratories
and is used notably to evaluate the prevalence of chronic bee paralysis
in Europe (EPILOBEE Consortium et al., 2016).
In 2015, the EURL for honeybee health organized an inter-labora-
tory comparison (ILC) in order to assess the analytical ability of the
participating laboratories to quantify CBPV genomic RNA in bees. The
ILC was organised following the requirements of NF EN ISO/CEI 17043
(2015). This report presents a statistical analysis of performance for the
quantitative data reported by the participating laboratories. The accu-
racy (trueness and precision combined) of the results was evaluated
according to international standards (NF ISO 13528 (2015) and NF ISO
5725-2 (1994)).
2. Material and method
2.1. Healthy bees
Three hundred emerging honeybees were collected in healthy
honeybee colonies originated from one of the ANSES laboratory api-
aries (ANSES, Sophia Antipolis, France), during the autumn of 2014.
These bees were found to be CBPV-negative or with a CBPV load below
the quantiﬁcation limit of the RT-qPCR method.
2.2. CBPV-infected bees
Dead bees and trembling bees were collected in front of a sympto-
matic colony from one of the ANSES laboratory apiaries (ANSES,
Sophia Antipolis, France), during the spring of 2014. The samples were
identiﬁed as Sophia-2014-H20 according to the harvesting location, the
sampling date, and the hive number. The diagnosis of chronic bee pa-
ralysis virus disease was established by RT-qPCR (Blanchard et al.,
2012) and the CBPV isolate was characterised by sequencing the am-
plicon (Beckman Coulter Genomics) obtained by a conventional PCR
targeting the CBPV RNA polymerase coding sequence (Blanchard et al.,
2008).
2.3. Inter-comparison samples
Healthy bees were crushed for negative bee homogenates. Bees in-
fected by the CBPV isolate Sophia-2014-H20 were used as positive
samples. Bees were crushed in a pH 7.0 phosphate buﬀer (1 ml per bee)
using an Ultra-Turax tube drive. The bee homogenates were clariﬁed by
centrifugation according to a previously published protocol (Blanchard
et al., 2007). The viral load in the bee homogenate was adjusted to
three levels (5, 8 and 10 log10 CBPV/bee) by diluting the positive bee
homogenates in negative bee homogenates. The bee homogenates were
aliquoted in 0.5 ml (using 2 ml tubes with O-ring cap) and conserved at
below −70 °C. Each participant (21 participants in all) received three
samples of bee homogenate adjusted to 5 log10 CBPV/bee, ﬁve samples
adjusted to 8 log10 CBPV/bee, and ﬁve samples adjusted to 10 log10
CBPV/bee. The samples were packed by the EURL in accordance with
IATA packing instruction 650 (UN3373 − Biological Substance, Cate-
gory B). The triple-layered parcel was composed of an outer cardboard
box, an isotherm box containing the sample box and two ice packs. The
parcel was shipped in March 2015 at ambient temperature by an ap-
proved transporter (Trans Medical Service). The parcel was delivered
within the following three days except for one participant, who re-
ceived the parcel six days later. The organiser, involved as a participant,
received the comparative samples two days later.
Reference method for quantifying the CBPV genome
The reference method (used by the EURL, accredited as a testing
laboratory according to international standard ISO 17025) was based
on the viral RNA puriﬁcation and TaqMan® two-step RT-qPCR. This
method had been previously validated according to the French standard
NF U47-600 (Blanchard et al., 2012). Brieﬂy, total RNAs were puriﬁed
from 200 μl of clariﬁed bee homogenate using the High Pure Viral RNA
F. Schurr et al. Journal of Virological Methods 248 (2017) 217–225
218
Kit (Roche Diagnosis) according to the manufacturer’s instructions. The
RNAs were recovered from a spin column in 50 μl of elution buﬀer. The
complementary DNA (cDNA) was synthesised at 42 °C for 1 h in reverse
transcriptase buﬀer (50 mM Tris HCl pH 8.3, 75 mM KCl, 3 mMMgCl2),
0.5 mM dNTP’s, 20 pmol of random hexamer primers, 20 U of RNase
Out (Invitrogen), 200 U of SuperScript II reverse transcriptase (In-
vitrogene) and 12.5 μl of extracted RNA, in a total volume of 20 μl. The
ampliﬁcation reaction was subsequently performed in duplicate, in a
MicroAmp optical 96-well reaction plate containing 1X Taqman® Uni-
versal PCR Master Mix with uracil-N-glycosylase (UNG) (2X, Applied
Biosystems), 320 nM of each forward and reverse primers (qCBPV9: 5′-
CGC AAG TAC GCC TTG ATA AAG AAC −3′; qCBPV10: 5′- ACT ACT
AGA AAC TCG TCG CTT CG− 3′), 200 nM of the qCBPV probe (5′- (6-
Fam) TCA AGA ACG AGA CCA CCG CCA AGT TC (Tamra)-3′), 1X Exo
IPC Mic VIC (10X, Applied Biosystems), 1X Exo IPC DNA (50X, Applied
Biosystems) and 5 μl of cDNA template in a ﬁnal volume of 25 μl. The
thermal cycling conditions were 2 min at 50 °C (active temperature for
UNG to degrade any carryover DNA ampliﬁed from previous reactions),
10 min at 95 °C (activation of AmpliTaq Gold DNA Polymerase and
degradation of UNG), followed by 40 denaturation cycles at 95 °C for
15 s and annealing/extension at 60 °C for 1 min. The results are ex-
pressed as the mean of the two replicates for each reaction.
2.4. Method implemented in the participant laboratories
A total of 21 laboratories participated in the ILC: 15 European NRLs
(from Belgium, Croatia, Denmark, Finland, France, Germany, Hungary,
Italy, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden and the
United Kingdom), ﬁve French laboratories from an accredited network
diagnosing chronic bee paralysis by RT-qPCR (EPILOBEE Consortium
et al., 2016), and the Canadian NRL.
The available data concerning the implementation of the RT-qPCR
method described by Blanchard et al. (2012) in the 21 participating
laboratories are presented in supplementary Table S1. The laboratories
used commercial kits from several suppliers for RNA puriﬁcation, cDNA
synthesis and real-time PCR. The RT-qPCR results were converted into
log10 CBPV/bee taking into account the volume of bee homogenate
tested, the volume of the elution buﬀer used for RNA recovery from the
spin column, the volume of puriﬁed RNA used for cDNA synthesis and
the volume of cDNA tested by real-time PCR in each NRL. All the NRLs
participating in the ILC used the same primers (Blanchard et al., 2007)
and the same batch of pAb2 clone (quantiﬁed by spectrometry at
260 nm) provided by the organiser. The pAb2 clone (recombinant
plasmid with CBPV PCR-targeted sequence) was used to establish the
calibration curves for quantiﬁcation of the CBPV load in the range of
2.0 to 8.0 log10 copies per 5 μl (Blanchard et al., 2012).
2.5. Sequence analysis
RT-PCR products were puriﬁed by using the QIAquick PCR
Puriﬁcation kit (Qiagen) and direct sequencing of both strands was
performed by Beckman (France). Sequence alignments and phyloge-
netic trees were calculated with the CLUSTAL X (version 1.81) analysis
program (Thompson et al., 1997). Conﬁdence values were determined
by the bootstrapping method, as implemented in CLUSTAL X. Visuali-
zation of the phylogenetic trees was performed using TREEVIEW, ver-
sion 1.6.6 (Page, 1996).
2.6. Sample homogeneity and stability
The homogeneity and stability tests were performed by the EURL.
The homogeneity of ten randomly selected positive samples stored at
below −70 °C (tested in replicate) was estimated by calculating the
standard deviations (Ss) between samples according to the formula in
Annex B of international standard NF ISO 13528 (2015). This Ss was
expected to be about 0.5 log10 CBPV/bee or below.
To test the sample stability during shipment, each positive sample
was packaged as previously described. One parcel was kept at a tem-
perature of 23 °C for 72 h. A second parcel was exposed to temperatures
that could possibly occur during the transport to the Canadian labora-
tory (72 h at 23 °C and 88 h at 10 °C). The samples were kept at below
−70 °C before analysis to test the stability of CBPV RNA.
2.7. Statistical analyses
The participant’s data on CBPV quantiﬁcation and the method used
Fig. 1. Neighbour-joining phylogenetic tree constructed using 523 nt from published sequences of the CBPV RNA polymerase coding sequence (deposited in GenBank database) and the
sequence of CBPV isolate Sophia-2014-H20 (Accession number: KX779523) selected for the inter-laboratory comparison (arrow). The sequences are identiﬁed by the CBPV isolate name
(accession number provided in Supplementary Table S2). The phylogenetic tree was rooted using the CBPV isolates BE104 and 3NZ as outgroup. The numbers close to the nodes indicate
the bootstrap values (in %; 1000 replicates). Bar: number of substitutions per site.
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were registered and analysed by the EURL. The assigned values (robust
mean: X*, the robust standard deviation: S*, the standard deviation of
repeatability: Sr, and the standard deviation of reproducibility: SR) of
the viral loads (5, 8 or 9 log10 CBPV/bee) were calculated according to
international standard NF ISO 13528 (2015) (using the A algorithm
described in Appendix C) using the overall viral loads (x) found by the
participants. The trueness of the participant’s data was assessed using
the statistical tests (z-score: z= [x − X*]/S*) also described in this
international standard.
The mean standard deviation (Smean) was calculated for each viral
load using the standard deviations found by the participants for each
sample (s), and the assessment of the precision (Mandel’s k: k= k’ [s/
Smean] with the k’ coeﬃcient found in Mandel’s k table at the 1% sig-
niﬁcance level) of the NRL’s data was calculated according to interna-
tional standard NF ISO 5725-2 (1994).
3. Result
3.1. Virus characterisation
The partial RNA-dependent RNA polymerase coding sequence of the
Sophia-2014-H20 viral isolate was ampliﬁed and sequenced (GenBank
accession number: KX779523). Fig. 1 shows that the isolate belongs to a
phylum distant from the A-79P reference strains (GenBank accession
number: EU122229.1). The sequence clustered in a lineage with a CBPV
sequence obtained also in 2014 from another apiary located in France
(isolate Orleans-2014, GenBank accession number: KX779524).
3.2. Sample homogeneity and stability
Before shipment, the Ss value was calculated for all the samples
containing 5, 8, or 9 log10 CBPV/bee (Table 1). These values were
within a range of 0.52 to 0.58 log10 and were higher than the expected
value (0.5 log10 CBPV/bee). However, estimated Ss values were lower
than the robust standard deviation S*. Therefore, the samples were
considered to be suﬃciently homogeneous.
The stability of the samples after storage mimicking the shipment
time and temperatures is shown in Table 1. Variations in the viral load
were within the laboratory conﬁdence range of the RT-qPCR estimated
for the homogeneity test (+/− 1.96 Ss). No signiﬁcant reduction in the
log10 CBPV/bee was found by RT-qPCR.
3.3. Sensitivity
Three samples containing 5 log10 CBPV/bee were analysed by the
21 participating laboratories (Fig. 2.a). One participant (coded O) did
not detect CBPV in these samples. Taking into account the overall re-
sults (60 samples detected positive out of 63 tested samples), the di-
agnostic sensitivity was estimated to be about 95%. The samples with
the highest viral loads (8 and 9 log10 CBPV/bee; Figs. 2.b and 2.c) were
tested positive by all the participants (210 tested samples). The diag-
nostic sensitivity concerning samples with these highest viral loads was
thus 100%.
3.4. Raw data and assigned values of the inter-laboratory comparison
samples
The results of virus quantiﬁcation obtained on the replicate analyses
at the three viral loads were used to assess the accuracy of the parti-
cipant’s method (Fig. 2). For each viral load, the assigned values were
the consensual values calculated using the overall participant data
(Table 1). The only data excluded from the statistical analysis were the
negative results obtained by participant O testing samples with the
lowest viral load (5 log10 CBPV/Bee). The robust mean (X*) calculated
at the three viral loads (5.58, 8.02, and 9.24 log10 CBPV/bee) were in
accordance with the expected values deﬁned by the organiser (Table 1).
Participant A, using the reference method described in this report, was
one of the participants providing the most accurate results. No corre-
lation was found between participant results and shipment time (three
or six days for participants D, H, K, M, N, P and U), or the real-time PCR
chemistry (participants Q and U used the SYBR-green chemistry while
the others used the TaqMan chemistry), even with the use of single
reaction RT-qPCR (participants E, F, G, K, N, P, Q, R, and T). The two
components of accuracy are subsequently described as trueness and
precision.
3.5. Assessment of the trueness of results
The values of the z-scores are shown in three histograms corre-
sponding to the inter-laboratory comparison samples at the three viral
loads (Fig. 3). Three participants provided unexpected results (partici-
pant codes D, T and O). As indicated previously, participant O found
unexpected negative results when testing the samples containing 5.58
log10 CBPV/bee. At this lowest viral load, participants D and T found
measurements statistically diﬀerent from the assigned values
(p< 0.05). The z-scores of participant D were below −3.0, indicating
Table 1
Homogeneity, stability, and assigned value of the inter-laboratory comparison samples. The results are expressed as log10 CBPV genome copies per bee. Homogeneity was evaluated using
the aliquots of inter-laboratory comparison samples stored at below −70 °C. The both incubations mimicking the shipping conditions were used for the stability assessment. Robust
statistics (algorithm A described in Appendix C of the NF ISO 13528 (2015) international standard) were used to calculate the assigned values of the inter-laboratory comparison samples
at the three viral loads: 5, 8, and 9 log10 CBPV/bee.
Stability Inter-laboratory comparison
Viral load (log10 CBPV/bee) Homogeneity 72 h at 23 °C 72 h at 23 °C and 88 h at 10 °C Acceptance range4 Assigned values
Mean Ss1 n2 Mean Variation3 n Mean Variation n X*5 S*6 Sr7 SR8 U9 n
5 4.74 0.56 20 5.00 0.26 9 5.14 0.40 3 [3.64-5.84] 5.58 0.82 0.15 0.83 1.63 60
8 7.69 0.58 20 6.98 -0.71 13 7.29 -0.40 3 [6.55-8.33] 8.02 1.05 0.13 1.06 2.08 105
9 8.86 0.52 20 8.28 -0.58 13 8.71 -0.15 3 [7.84-9.88] 9.24 1.16 0.11 1.16 2.27 105
1 Ss: standard deviation between samples.
2 n: number of data.
3 Variationn = stability mean− homogeneity mean.
4 Acceptance range = homogeneity mean +/− 1.96 Ss.
5 X*: Robust mean.
6 S*: Robust standard deviation.
7 Sr: repeatability standard deviation.
8 SR: reproducibility standard deviation.
9 U: measurement uncertainty (1.96 SR).
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Fig. 2. Experimental results obtained by the participants (coded A to U) quantifying the CBPV in the inter-laboratory comparison samples. Three replicates containing 5 log10 CBPV/bee
(Fig. 2.a) and ﬁve replicates containing 8 or 9 log10 CBPV/bee (Figs. 2.b and 2.c, respectively) were tested by each participant. The black bullets indicate the number of CBPV genome
copies per bee (log10 CBPV/bee) quantiﬁed by RT-qPCR. The empty box is the participant’s mean value. The dashed lines indicate the robust mean (X*). The negative results found by
participant O testing the samples adjusted to 5 log10 CBPV/bee are not shown in Fig. 2.a.
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that the participant’s data was signiﬁcantly lower than the assigned
value and outside the 99% conﬁdence range. The z-scores of participant
T (between 2.0 and 3.0) indicated overestimations of the viral load
outside the 95% conﬁdence range.
3.6. Assessment of the precision of results
The k values were compared to an indicator derived from Mandel’s
statistical table at the 1% signiﬁcance level. The participants’ data were
Fig. 3. z-scores calculated for each participant (coded A to U)
quantifying the CBPV in the inter-laboratory comparison
samples. The grey boxes indicate the individual z-score for the
three replicates containing 5 log10 CBPV/bee (Fig. 3.a) and ﬁve
replicates containing 8 or 9 log10 CBPV/bee (Figs. 3.c and 3.d
respectively) tested by each participant. The dashed and solid
lines indicate the limits of +/− 2 and +/− 3 respectively.
For the viral load 5 log10 CBPV/bee, the negative results found
by participant O are not taken into account.
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usable because less than 25% of k values were above the critical
threshold value. The k graphs (Fig. 4) reveal variability between re-
plicate test results for participant M (at the viral load 9 log10 CBPV/bee)
and participant S (at the viral loads 8 and 9 log10 CBPV/bee).
4. Discussion
An estimation of the viral load in biological samples may be used in
the diagnosis and management of chronic diseases (Gullett and Nolte,
Fig. 4. Mandel’s k calculated for each participant
(coded A to U) quantifying the CBPV in the inter-la-
boratory comparison samples. The black boxes in-
dicate the k value calculated for three replicates con-
taining 5 log10 CBPV/bee (Fig. 4.a) and ﬁve replicates
containing 8 or 9 log10 CBPV/bee (Figs. 4.b and 4.c)
tested by each participant. The solid lines indicate the
k’ limit found in Mendel’s k table at the 1% sig-
niﬁcance level. For the 5 log10 CBPV/bee level, the
negative results found by participant O are not taken
into account.
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2015). Indeed, a variation in the number of viral genome copies reﬂects
a breakdown in the balance between the parasite and its host, leading to
the adverse eﬀects of virus replication. Viral loads are also used to
monitor eﬀects of antiviral treatment. The accuracy of the measurement
is of particular importance, especially when data provided by diﬀerent
laboratories are compared. A recent report by the European Commis-
sion compared the prevalence of chronic bee paralysis in Europe by
analysing the CBPV load in symptomatic bees quantiﬁed by RT-qPCR in
several laboratories (Laurent et al., 2015). The threshold for diagnosis
of chronic bee paralysis was set at 8 log10 CBPV/bee by previous studies
(Blanchard et al., 2007). The French data of CBPV loads in bees were
collected by a network of accredited laboratories using the oﬃcial
method previously developed and validated by the EURL for honeybee
health (Blanchard et al., 2012). Before performing viral diagnosis, these
laboratories had adopted the method in accordance with the French
standard NF U47-600-1 (2015). This standard describes the tests that
should be performed using standard samples in order to guarantee the
method. In other countries reporting quantitative data, the methods
used to quantify CBPV were adapted from the oﬃcial method without
the preliminary tests described in the French standard. Consequently,
the accuracy was not known for most of the laboratories prior to this
study. Moreover, the accuracy strongly depends on controlling key
points in the analytical process. The analytical process as a whole
should be regulated in the laboratory’s organisation in line with the
international standard for diagnostic laboratories (NF EN ISO/CEI
17025, 2005) and recognised by an accreditation body. For example,
the reference method for the quantiﬁcation of CBPV has been validated
and accredited for use in the EURL (Blanchard et al., 2012). The same
approach can be used to manage the accuracy in intra-laboratory con-
ditions while the sources of inter-laboratory variations must be esti-
mated by comparing data obtained from several laboratories testing
identical samples. In this report, we estimate trueness and precision
(two components of accuracy) of the RT-qPCR for quantifying CBPV in
bee homogenates by an ILC. The ILC was organised in keeping with
international standard NF EN ISO/CEI 17043 (2015) in order to obtain
reliable data.
The matrices of the inter-laboratory comparison samples were se-
lected to minimise the variability in the results not directly related to
the performance under evaluation. By more than 100 measurements of
viral loads (in samples before and after storage in conditions mimicking
the shipment), we showed that the number of CBPV genome copies in
honeybee homogenate was both suﬃciently homogeneous and stable.
All the honeybee homogenates were prepared by the ILC organiser.
Consequently, the analysis of performance of the method reported here
did not cover variability related to upstream processing steps such as
sampling and sample preparation. The laboratories diagnosing chronic
bee paralysis currently take in account variability in the viral load of
naturally infected bees by testing a pool of symptomatic honeybees
(from 8 to 10 bees being recommended by the EURL). The performance
of the methods evaluated in this report was inﬂuenced by all the steps
of the process, from puriﬁcation of the RNA to the qPCR reaction
measured as a log10 number of CBPV genome copies per bee.
We also show that the detection sensitivity of CBPV by RT-qPCR at
the lower viral load (5 log10 CBPV/bee) was about 95% (60 positive
results out of 63 samples tested). Only one participant (participant O)
did not detect CBPV genome at the lowest CBPV load which was se-
lected to be about 100 fold over the reference method’s limit of de-
tection (Blanchard et al., 2012). This participant had received the
samples within an appropriate delay (2 days later). One explanation of
the negative results obtained by participant O was the use of an ex-
cessive internal positive control (supplementary Table S1) that could be
in competition with the CBPV RNA (both targets being ampliﬁed during
the same qPCR reaction). However, a limit of detection of about 5 log10
CBPV/bee should have a limited impact on the results expected when
diagnosing the clinical disease because all the participants were able to
detect the CBPV RNA in samples adjusted to 8 or 9 log10 CBPV/bee.
To assess the accuracy we assessed both trueness and precision.
International standard NF ISO 5725-1 (1994) provides deﬁnitions of
these performance criteria. Brieﬂy, trueness is the closeness of agree-
ment between the mean value obtained from a large series of test results
and an accepted reference value. The measurement of trueness is
usually expressed in terms of bias, which is the diﬀerence between the
expected test results and an accepted reference value (Bias = x-X*;
with x= the observed result, and X* = the reference value). Bias is the
total systematic error. In our study, we calculated z-scores to assess bias
in participant data instead of Mandel’s h as described in the NF ISO
5725-2 (1994) standard. This choice was made because we also used
the robust statistical analysis described in the NF ISO 13528 (2015)
standard. The reference values were estimated without excluding data,
while Mandel’s h is calculated after excluding aberrant data identiﬁed
by statistical tests (Cochran and Grubbs tests). The robust statistical
analysis revealed the systematic errors of each participant’s method.
The real viral load in the samples was estimated in terms of consensual
values (X*). The latter were close to the mean values found by the EURL
during the sample homogeneity and stability experiments (Table 1).
Global bias was minimised by all participants using the same clone for
generating the standard curves of the RT-qPCR methods. We considered
that this is a crucial element in the harmonisation of methods to reduce
systematic error. The stability of the samples and absence of variation
in the results correlated with the shipment time exclude any systematic
error arising from the study’s organisation. At the estimated diagnostic
threshold level (8 log10 CBPV/bee), ﬁve participants found mean values
at least 1-log10 over (participants T and U) or under (participants B, D,
and O) the robust mean (Fig. 2.b). However, no laboratory provided
results signiﬁcantly diﬀerent from the assigned value no z-score< -2 or
z-score> 2reported in Fig. 3.b). An alternative approach to reduce bias
is suggested in the French standard NF U47-600-1 (2015), which de-
scribes the use of a reference material adjusted to the diagnostic
threshold. The standard material should be calibrated by a reference
laboratory or according to inter-laboratory testing. This reference ma-
terial should be used systematically in the same RT-qPCR run so as to be
able to compare the Cq (quantiﬁcation cycle) values found with the
reference material and the tested samples. Samples with a Cq-value
lower than the Cq-value of the reference material can be considered as
clinical case samples. In this ILC, the homogenate with the assigned
value found at 8.02 log10 CBPV/bee could be considered the reference
material (Table 1). However, for this purpose, very large amounts of
reference material should have been prepared in order to satisfy the
requirements of NRLs. This could be the aim of future reference ma-
terial developments.
Another criterion evaluated in this study is each participating la-
boratory’s precision of measurement. Precision is the closeness of
agreement between independent test results obtained under stipulated
conditions. It depends only on the distribution of random errors and
does not relate to the true value of the speciﬁed value. Precision can be
characterised by two components: repeatability and reproducibility.
Repeatability is precision under the condition that test results are ob-
tained with the same method on identical test items in the same la-
boratory by the same operator using the same equipment within short
intervals of time. Global repeatability is described in the present study
as Sr (Table 1). Moreover, in this report, Mandel’s k value provides an
evaluation of the participant’s repeatability compared to the repeat-
ability mean found in the ILC (Smean). Notably, the repeatability of viral
loads found by participant S was signiﬁcantly higher than the others at
two viral loads (Figs. 4.b and 4.c). The high PCR eﬃciency (134%)
found by participant S could be the cause of random errors. The ac-
cepted range of PCR eﬃciency was 75%-125% (NF U47-600-2, 2015).
Accurate pipetting with regularly calibrated pipettes is critical in order
to obtain accurate and precise data. Consistent pipetting of excess
standard sample or pipetting of insuﬃcient diluent in serial dilutions
could increase PCR eﬃciency. Reproducibility is precision under the
condition that test results are obtained with the same method on
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identical test items in diﬀerent laboratories by diﬀerent operators using
diﬀerent equipment. SR was used to estimate the inter-laboratory con-
ﬁdence of viral quantiﬁcation (+/− 1.96 SR). For diagnostic viral load
(8 log10 CBPV/bee), this conﬁdence was estimated to be +/− 2.08
log10 CBPV/bee. In the current quest to harmonise methods for quan-
tifying CBPV in honeybees, viral loads between 6 and 8 log10 CBPV/bee
found in symptomatic honeybees could be considered to indicate
probable cases of viral chronic bee paralysis.
In conclusion, the international network of NRLs responsible for
diagnosing chronic bee paralysis by RT-qPCR provided accurate results
in this ILC. No signiﬁcant systematic error (trueness) was found in the
estimation of the number of genome copies in honeybee homogenates
adjusted to the diagnostic threshold (8 log10 CBPV/bee). Only one la-
boratory had a lower precision (random error) than the others.
However, the global uncertainty of measurements estimated in this
study (+/− 2.08 log10 CBPV/bee) should be taken into account in
epidemiological studies on the prevalence of clinical chronic bee pa-
ralysis by interpreting the data from diﬀerent laboratories. The accu-
racy could be improved by including a standard samples adjusted by the
EURL to a diagnostic threshold.
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